C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
167/103.46
C07K 14/655 (2006.01) A61K 38/31 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1250234
-45- ABSTRACT OF THE DISCLOSURE A method of increasing the clearance of particles from the blood stream of a vertebrate, which comprises administering to a vertebrate having a surplus of particles in the blood stream of the vertebrate an amount of a somatostatin analogue sufficient to increase phagocytosis in the vertebrate is disclosed along with a method treating vascular lesions or deterioration of biological membranes comprising the step of administering to a human or other mammal suspected of having one or more vascular lesions or of having deterioration of a biological membrane in the liver of said human or mammal an amount of a somatostatin analogue sufficient to reduce the number or severity of said lesions or to prevent further deterioration or reduce the extent of deterioration of said membrane.
467632
Kessler Horst
Szabo Sandor
Usadel Klaus H.
Brigham And Women's Hospital
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Clinical use of somatostatin analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clinical use of somatostatin analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clinical use of somatostatin analogues will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1182011